A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain
NCT01676493 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2018-10-02
Summary
This is a multicenter, open-label study to evaluate the safety and PK of oral codeine sulfate in pediatric subjects with mild to moderate post-procedural pain.
Conditions
Interventions
- DRUG
-
Codeine
Sponsors & Collaborators
-
Quintiles, Inc.
collaborator INDUSTRY -
Roxane Laboratories
lead INDUSTRY
Principal Investigators
-
Dante Landucci, MD · Quintiles, Inc.
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- United States
Study Locations
More Related Trials
-
Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children
NCT04681027 ·Status: SUSPENDED ·Phase: PHASE3
-
Dose Linearity Study of Codeine Sulfate Under Fasted Conditions
NCT01009697 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
NCT01369615 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
NCT00765856 ·Status: TERMINATED ·Phase: PHASE3
-
An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
NCT00465647 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NCT02767349 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects
NCT01959204 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Oral Morphine and Pharmacogenomics of CYP2D6 and UGT2B7, in an Urban Pediatric Population Presenting for Elective Surgery
NCT01071499 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients
NCT01160614 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics (PK), and Effectiveness of Hydrocodone Bitartrate (HYD) Extended-Release Tablets in Children
NCT02542098 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release
NCT00994383 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NCT02508935 ·Status: TERMINATED ·Phase: PHASE4
-
Dose Proportionality and Food Effect of Morphine Sulfate
NCT00994539 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy
NCT00271453 ·Status: COMPLETED ·Phase: PHASE3
-
Omnitram Pharmacokinetic Study In Healthy Volunteers
NCT02205554 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
NCT00943566 ·Status: WITHDRAWN ·Phase: PHASE2
-
Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects
NCT02576353 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient
NCT01482936 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
NCT00271466 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
NCT01965158 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously
NCT00996177 ·Status: COMPLETED ·Phase: PHASE4
-
Narcotic-Free Percutaneous Nephrolithotomy
NCT05924165 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
NCT01648699 ·Status: TERMINATED ·Phase: PHASE4
-
A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy
NCT00271414 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
NCT00952068 ·Status: COMPLETED ·Phase: PHASE2